Invention Grant
- Patent Title: Aminoimidazopyridazines as kinase inhibitors
-
Application No.: US16758892Application Date: 2018-10-29
-
Publication No.: US11440913B2Publication Date: 2022-09-13
- Inventor: Michael E. Mertzman , Carolyn Diane Dzierba , Jason M. Guernon , Amy C. Hart , Guanglin Luo , John E. Macor , William J. Pitts , Jianliang Shi , Steven H. Spergel
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee Address: US NJ Princeton
- Agent Mary K. VanAtten
- International Application: PCT/US2018/057968 WO 20181029
- International Announcement: WO2019/089442 WO 20190509
- Main IPC: A61K31/5025
- IPC: A61K31/5025 ; C07D487/04
Abstract:
Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, (I) are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein.
Public/Granted literature
- US20200277296A1 AMINOIMIDAZOPYRIDAZINES AS KINASE INHIBITORS Public/Granted day:2020-09-03
Information query
IPC分类:
